BIOMAT Database Logo BIOMAT Database Logo

Novel isoxazoline-linked 1,3,4-thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation. 2022

Ali Oubella, and Said Byadi, and Abdoullah Bimoussa, and Mourad Fawzi, and Aziz Auhmani, and Crtomir Podlipnik, and Hamid Morjani, and Abdelkhalek Riahi, and Anthony Robert, and My Youssef A Itto
Laboratory of Organic Synthesis and Physico-Molecular Chemistry, Department of Chemistry, Faculty of Sciences Semlalia, Marrakesh, Morocco.

In the current study, natural (R)-carvone was utilized as a starting material for the efficient synthesis of two series of isoxazoline derivatives bearing the 1,3,4-thiadiazole moiety. The new compounds were obtained in good yields and were characterized by 1 H and 13 C NMR and HRMS analysis. The newly synthesized monoterpenic isoxazoline 1,3,4-thiadiazole and their thiosemicarbazone intermediate derivatives were evaluated for their anticancer activity in four cancer cell lines (HT-1080, A-549, MCF-7, and MDA-MB-231). Most of the synthesized compounds exhibited moderate to high anticancer effects. Compound 13c showed the highest anticancer activity with IC50 values ranging from 19.33 ± 1.81 to 34.81 ± 3.03 µM. Further investigation revealed that compounds 12e and 13c could inhibit the cell growth of HT-1080 and MCF-7 cells by inducing apoptosis through caspase-3/7 activation. The apoptotic effect was accompanied by an S phase and G2/M cell cycle arrest for 13c and 12e, respectively. Compounds 12e and 13c were assessed in silico using molecular docking and molecular dynamics. We found that compound 13c is moderately active against the caspase-3 protein, which triggers apoptosis via intrinsic and extrinsic routes, making compound 13c a promising candidate to activate the proapoptotic protein (caspase-3).

UI MeSH Term Description Entries
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000737 Androstenols Unsaturated androstanes which are substituted with one or more hydroxyl groups in any position in the ring system. Hydroxyandrostenes
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D053148 Caspase 3 A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 9. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA. CASP3,Apopain,Caspase-3,Pro-Caspase-3,Procaspase-3,Pro Caspase 3,Procaspase 3

Related Publications

Ali Oubella, and Said Byadi, and Abdoullah Bimoussa, and Mourad Fawzi, and Aziz Auhmani, and Crtomir Podlipnik, and Hamid Morjani, and Abdelkhalek Riahi, and Anthony Robert, and My Youssef A Itto
Synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as possible anticancer agents.
December 2020, Acta pharmaceutica (Zagreb, Croatia),
Ali Oubella, and Said Byadi, and Abdoullah Bimoussa, and Mourad Fawzi, and Aziz Auhmani, and Crtomir Podlipnik, and Hamid Morjani, and Abdelkhalek Riahi, and Anthony Robert, and My Youssef A Itto
Design, Synthesis, and Molecular Docking Study of Novel Heterocycles Incorporating 1,3,4-Thiadiazole Moiety as Potential Antimicrobial and Anticancer Agents.
March 2019, Molecules (Basel, Switzerland),
Ali Oubella, and Said Byadi, and Abdoullah Bimoussa, and Mourad Fawzi, and Aziz Auhmani, and Crtomir Podlipnik, and Hamid Morjani, and Abdelkhalek Riahi, and Anthony Robert, and My Youssef A Itto
Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations.
February 2024, BMC chemistry,
Ali Oubella, and Said Byadi, and Abdoullah Bimoussa, and Mourad Fawzi, and Aziz Auhmani, and Crtomir Podlipnik, and Hamid Morjani, and Abdelkhalek Riahi, and Anthony Robert, and My Youssef A Itto
Design, Synthesis, Anticancer Evaluation, and Molecular Docking Studies of Novel Benzoxazole Linked 1,3,4-Oxadiazoles.
January 2022, Anti-cancer agents in medicinal chemistry,
Ali Oubella, and Said Byadi, and Abdoullah Bimoussa, and Mourad Fawzi, and Aziz Auhmani, and Crtomir Podlipnik, and Hamid Morjani, and Abdelkhalek Riahi, and Anthony Robert, and My Youssef A Itto
Synthesis, Molecular Docking and Evaluation of 1,3,4-Oxadiazole-Isobenzofuran Hybrids as Antimicrobial and Anticancer Agents.
May 2022, Chemistry & biodiversity,
Ali Oubella, and Said Byadi, and Abdoullah Bimoussa, and Mourad Fawzi, and Aziz Auhmani, and Crtomir Podlipnik, and Hamid Morjani, and Abdelkhalek Riahi, and Anthony Robert, and My Youssef A Itto
Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
February 2011, European journal of medicinal chemistry,
Ali Oubella, and Said Byadi, and Abdoullah Bimoussa, and Mourad Fawzi, and Aziz Auhmani, and Crtomir Podlipnik, and Hamid Morjani, and Abdelkhalek Riahi, and Anthony Robert, and My Youssef A Itto
Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents.
February 2012, Bioorganic & medicinal chemistry,
Ali Oubella, and Said Byadi, and Abdoullah Bimoussa, and Mourad Fawzi, and Aziz Auhmani, and Crtomir Podlipnik, and Hamid Morjani, and Abdelkhalek Riahi, and Anthony Robert, and My Youssef A Itto
Novel quinazoline-chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies.
November 2023, Archiv der Pharmazie,
Ali Oubella, and Said Byadi, and Abdoullah Bimoussa, and Mourad Fawzi, and Aziz Auhmani, and Crtomir Podlipnik, and Hamid Morjani, and Abdelkhalek Riahi, and Anthony Robert, and My Youssef A Itto
Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents.
October 2014, European journal of medicinal chemistry,
Ali Oubella, and Said Byadi, and Abdoullah Bimoussa, and Mourad Fawzi, and Aziz Auhmani, and Crtomir Podlipnik, and Hamid Morjani, and Abdelkhalek Riahi, and Anthony Robert, and My Youssef A Itto
Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents.
May 2012, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!